Related Experiment Video
Updated: Apr 11, 2026
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
3.3K
Non-Benzodiazepine Receptor Agonists for Insomnia
Philip M Becker1, Manya Somiah2
1Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; Sleep Medicine Associates of Texas, 5477 Glen Lakes Drive, Suite 100, Dallas, TX 75231, USA.
Sleep Medicine Clinics
|June 10, 2015
Summary
Non-benzodiazepine receptor agonists (non-BzRA) are widely prescribed for insomnia due to their effectiveness and safety. This review covers their benefits, risks, and selection criteria for hypnotic therapy.
Area of Science:
- Pharmacology
- Sleep Medicine
- Psychiatry
Background:
- Non-benzodiazepine receptor agonists (non-BzRA) are frequently prescribed for insomnia.
- Cognitive-behavioral therapy is the primary treatment for insomnia.
- Non-BzRA are favored for their efficacy and reduced side effect profiles compared to older hypnotics.
Purpose of the Study:
- To review the benefits and risks of non-BzRA.
- To define selection criteria for hypnotic agents.
- To provide guidance on pharmacologic management of insomnia.
Main Methods:
- Literature review of non-BzRA efficacy and safety.
- Analysis of pharmacologic profiles of hypnotic agents.
- Evaluation of adverse events associated with non-BzRA.
Main Results:
- Non-BzRA demonstrate proven efficacy in treating insomnia.
- These agents offer reduced side effects and lower addiction concerns.
- Selection should be based on efficacy, pharmacology, and adverse event profiles.
Conclusions:
- Non-BzRA are a preferred pharmacologic option for insomnia management.
- Careful consideration of individual patient factors is crucial for selecting hypnotics.
- Understanding the benefits and risks of non-BzRA supports optimal insomnia treatment.
Related Concept Videos
01:19Management of Insomnia
789
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
789
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
914
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
914
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
1.3K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.3K
01:23Sedatives and Hypnotics: Overview
2.1K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.1K
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.8K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.8K
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
3.1K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
3.1K